1. Home
  2. VNDA vs BLZE Comparison

VNDA vs BLZE Comparison

Compare VNDA & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • BLZE
  • Stock Information
  • Founded
  • VNDA 2002
  • BLZE 2007
  • Country
  • VNDA United States
  • BLZE United States
  • Employees
  • VNDA N/A
  • BLZE N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • BLZE Computer Software: Prepackaged Software
  • Sector
  • VNDA Health Care
  • BLZE Technology
  • Exchange
  • VNDA Nasdaq
  • BLZE Nasdaq
  • Market Cap
  • VNDA 289.0M
  • BLZE 249.2M
  • IPO Year
  • VNDA 2006
  • BLZE 2021
  • Fundamental
  • Price
  • VNDA $5.28
  • BLZE $4.65
  • Analyst Decision
  • VNDA Strong Buy
  • BLZE Strong Buy
  • Analyst Count
  • VNDA 3
  • BLZE 6
  • Target Price
  • VNDA $14.00
  • BLZE $9.50
  • AVG Volume (30 Days)
  • VNDA 993.5K
  • BLZE 948.3K
  • Earning Date
  • VNDA 10-29-2025
  • BLZE 11-06-2025
  • Dividend Yield
  • VNDA N/A
  • BLZE N/A
  • EPS Growth
  • VNDA N/A
  • BLZE N/A
  • EPS
  • VNDA N/A
  • BLZE N/A
  • Revenue
  • VNDA $212,074,000.00
  • BLZE $141,859,000.00
  • Revenue This Year
  • VNDA $14.32
  • BLZE $16.78
  • Revenue Next Year
  • VNDA $37.05
  • BLZE $13.99
  • P/E Ratio
  • VNDA N/A
  • BLZE N/A
  • Revenue Growth
  • VNDA 11.12
  • BLZE 15.73
  • 52 Week Low
  • VNDA $3.81
  • BLZE $3.94
  • 52 Week High
  • VNDA $5.70
  • BLZE $10.86
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 60.60
  • BLZE 24.00
  • Support Level
  • VNDA $4.72
  • BLZE $4.13
  • Resistance Level
  • VNDA $5.46
  • BLZE $4.77
  • Average True Range (ATR)
  • VNDA 0.24
  • BLZE 0.33
  • MACD
  • VNDA 0.09
  • BLZE -0.05
  • Stochastic Oscillator
  • VNDA 86.13
  • BLZE 24.16

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.

Share on Social Networks: